Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2012
Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell deathDennis C Ko, Eric R Gamazon, Kajal P Shukla, et al.
Journal of Proteome Research|September 14, 2017
Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination TherapyAmy L Stark, Ashraf G Madian, Sawyer W Williams, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathyLuis J Leandro-García, Susanna Leskelä, Carlos Jara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based ChemotherapyVictoria A Sanchez, Megan M Shuey, Paul C Dinh, et al.
Journal of the National Cancer Institute|November 15, 2023
Impact of pain and adverse health outcomes on long-term US testicular cancer survivorsPaul C Dinh, Patrick O Monahan, Sophie D Fosså, et al.
Cancer|July 21, 2021
Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime CohortMatthew R Trendowski, Jessica L Baedke, Yadav Sapkota, et al.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Cancer Medicine|September 13, 2022
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancerMohammad Shahbazi, Xindi Zhang, Paul C Dinh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathyHeather E Wheeler, Eric R Gamazon, Claudia Wing, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2012
Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell deathDennis C Ko, Eric R Gamazon, Kajal P Shukla, et al.
Journal of Proteome Research|September 14, 2017
Identification of Novel Protein Expression Changes Following Cisplatin Treatment and Application to Combination TherapyAmy L Stark, Ashraf G Madian, Sawyer W Williams, et al.
Ear and Hearing|January 24, 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric AssessmentsShirin Ardeshirrouhanifard, Sophie D Fossa, Robert Huddart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathyLuis J Leandro-García, Susanna Leskelä, Carlos Jara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2023
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based ChemotherapyVictoria A Sanchez, Megan M Shuey, Paul C Dinh, et al.
Journal of the National Cancer Institute|November 15, 2023
Impact of pain and adverse health outcomes on long-term US testicular cancer survivorsPaul C Dinh, Patrick O Monahan, Sophie D Fosså, et al.
Cancer|July 21, 2021
Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime CohortMatthew R Trendowski, Jessica L Baedke, Yadav Sapkota, et al.
Nature Communications|January 24, 2013
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Jessica Bockhorn, Rachel Dalton, Chika Nwachukwu, et al.
Cancer Medicine|September 13, 2022
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancerMohammad Shahbazi, Xindi Zhang, Paul C Dinh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2012
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathyHeather E Wheeler, Eric R Gamazon, Claudia Wing, et al.
Pageof 19